Benzinga | Jun 7, 2021 06:56AM EDT

Goldman Sachs Downgrades ArcBest to Neutral, Lowers Price Target to $71

Goldman Sachs analyst Jordan Alliger downgrades ArcBest (NASDAQ:ARCB) from Buy to Neutral and lowers the price target from $83 to $71.